Cargando…
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery
[Image: see text] Targeted protein degradation (TPD) is emerging as one of the most innovative strategies to tackle infectious diseases. Particularly, proteolysis-targeting chimera (PROTAC)-mediated protein degradation may offer several benefits over classical anti-infective small-molecule drugs. Be...
Autores principales: | Espinoza-Chávez, Rocío Marisol, Salerno, Alessandra, Liuzzi, Anastasia, Ilari, Andrea, Milelli, Andrea, Uliassi, Elisa, Bolognesi, Maria Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125329/ https://www.ncbi.nlm.nih.gov/pubmed/37101607 http://dx.doi.org/10.1021/acsbiomedchemau.2c00063 |
Ejemplares similares
-
Enriching Proteolysis
Targeting Chimeras with a Second
Modality: When Two Are Better Than One
por: Salerno, Alessandra, et al.
Publicado: (2022) -
PROTAC-Induced
Glycogen Synthase Kinase 3β Degradation
as a Potential Therapeutic Strategy for Alzheimer’s Disease
por: Guardigni, Melissa, et al.
Publicado: (2023) -
Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
por: Fiorillo, Annarita, et al.
Publicado: (2022) -
A perspective on multi-target drug discovery and design for complex diseases
por: Ramsay, Rona R., et al.
Publicado: (2018) -
Glycogen Synthase
Kinase 3β: A New Gold Rush
in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective
por: De Simone, Angela, et al.
Publicado: (2020)